Clue
Period and ovulation tracker app with cycle insights, fertility planning, and reproductive health resources.
85/100
Excellent
S
Security & Privacy
17/25
Strengths
- Clue's data is governed by German and European GDPR, and they've stated they will not comply with any subpoena demanding access to user data.
- You can request a copy of your tracked data to be sent to the email address associated with your Clue account.
- All personal data collected for providing their service is deleted by them as soon as it is no longer required for the purpose for which it was collected.
Concerns
- Motherboard (https://www.vice.com/en/article/data-marketplace-selling-clue-period-tracking-data/) reported that Clue period-tracking data was found on a data marketplace, raising questions about data-broker involvement.
- Extensive third-party data sharing with multiple vendors (analytics, marketing, monitoring, payment, support platforms) without granular user control explicitly stated.
Our Findings
- Clue demonstrates strong privacy through GDPR compliance, data minimization practices, encryption protocols, and user control over analytics consent, positioning it well for users. However, reported instances of period-tracking data appearing on data marketplaces and extensive third-party sharing, with limited granular controls, raise concerns about data-broker involvement and downstream data handling beyond the company's direct control. Users can request data deletion within one month, though recovery from third-party services may not be guaranteed.
Strengths
- Clue's data is governed by German and European GDPR, and they've stated they will not comply with any subpoena demanding access to user data.
- You can request a copy of your tracked data to be sent to the email address associated with your Clue account.
- All personal data collected for providing their service is deleted by them as soon as it is no longer required for the purpose for which it was collected.
- When your data is sent between your device and Clue servers, they use the Hypertext Transfer Protocol Secure (HTTPS).
- For Google Analytics, you can withdraw consent for this use of your data at any time. This withdrawal only applies to future activities.
- [auto] State it uses encryption (at rest and in transit)
Weaknesses
- Motherboard (https://www.vice.com/en/article/data-marketplace-selling-clue-period-tracking-data/) reported that Clue period-tracking data was found on a data marketplace, raising questions about data-broker involvement.
- Extensive third-party data sharing with multiple vendors (analytics, marketing, monitoring, payment, support platforms) without granular user control explicitly stated.
- Request the complete deletion of your data, including all past data sent to third-party services used for tracking and analysis, by emailing <trust@helloclue.com>. Your data will be deleted within 1 month.
What We Couldn't Find
- Any public controversy about this product's data handling
A
Accuracy
23/25
Strengths
- Have FDA clearance or approval
- Registered with other regulatory bodies (CE mark, TGA, etc.)
- Peer-reviewed published studies supporting this product's claims
- Have studies conducted independently (not company-funded)
- Studies have adequate sample sizes and rigorous design (RCT, blinded)
Our Findings
- The product demonstrates strong regulatory standing, with FDA clearance and international registrations, supported by peer-reviewed, independently conducted studies with rigorous methodology and adequate sample sizes. Marketing claims appear truthful with publicly stated accuracy rates and clear limitation disclaimers, further bolstered by legitimate partnerships with medical institutions and active professional involvement in development. However, the product would benefit from more clearly delineating clinical versus wellness features, and independent reviews regarding accuracy and reliability present a mixed picture.
Strengths
- Have FDA clearance or approval
- Registered with other regulatory bodies (CE mark, TGA, etc.)
- Peer-reviewed published studies supporting this product's claims
- Have studies conducted independently (not company-funded)
- Studies have adequate sample sizes and rigorous design (RCT, blinded)
- Aaccuracy rates or efficacy numbers publicly stated
- Have named partnerships with hospitals or academic institutions
- Medical professionals actively involved in product development
- Have partnerships for research purposes (not just marketing endorsements)
- Have independent expert or media reviews of this product
- Include clear disclaimers about its limitations
- Marketing language truthful and not overpromising
Weaknesses
- Could do better with clearly distinguishing between clinical and wellness features
What We Couldn't Find
- Independent reviews mixed about accuracy and reliability
F
Foundation
25/25
Strengths
- Founders or key leaders have direct women's health or clinical expertise
- Leaders have relevant healthcare or health-tech industry experience
- Engage in public advocacy or education on women's health
Our Findings
- Clue demonstrates exceptional strength across all evaluated areas, with leadership bringing direct women's health and clinical expertise, combined with relevant healthcare industry experience. The company has established credibility through transparent leadership information, a clearly defined and operationalized women's health mission, active clinical advisory support with qualified experts, and a demonstrated commitment to advancing the field through research and public advocacy. No concerns were identified in any aspect of the Foundation evaluation.
Strengths
- Founders or key leaders have direct women's health or clinical expertise
- Leaders have relevant healthcare or health-tech industry experience
- Leadership information publicly available and verifiable
- Have a specific, actionable women's health mission
- Mission reflected in actual product decisions and company actions
- Have a named advisory board or clinical consultants
- Advisors have relevant women's health credentials
- Advisors appear to have active, ongoing roles (not just names on a page)
- Published research or presented at conferences on women's health
- Engage in public advocacy or education on women's health
- Product's marketing respectful and educational
- Marketing align with the company's stated mission and values
- Marketing free of exploitative or misleading tactics
Weaknesses
- None noted.
E
Equity
20/25
Strengths
- Product available in multiple languages
- Representation of diverse body sizes, ages, and abilities
- Language is inclusive of LGBTQ+ and gender-diverse users
- A free tier that provides meaningful functionality
- Accommodate different bodies, cycles, or health conditions
Concerns
- Could improve on basic accessibility standards (screen reader support, sufficient contrast)
- Doesn't have an interface usable for people with varying tech literacy
- Doesn't offer financial assistance, sliding scale, or insurance coverage
Our Findings
- Clue demonstrates strong inclusive design across representation, language accessibility, and pricing structure, with evidence of diverse user testing and community partnerships. However, significant gaps exist in technical accessibility features—including screen reader support and adequate contrast ratios—and the interface may not accommodate users with lower technological literacy. Additionally, the lack of financial assistance options or insurance coverage integration limits accessibility for economically disadvantaged populations.
Strengths
- Product available in multiple languages
- Marketing imagery includes diverse racial and ethnic representation
- Representation of diverse body sizes, ages, and abilities
- Language is inclusive of LGBTQ+ and gender-diverse users
- A free tier that provides meaningful functionality
- Paid tier reasonably priced for the target audience
- Partner with community health organizations
- Outreach to underserved or marginalized communities
- Engage with user feedback from diverse communities
- Evidence the product was tested with diverse user groups
- Accommodate different bodies, cycles, or health conditions
Weaknesses
- Could improve on basic accessibility standards (screen reader support, sufficient contrast)
- Doesn't have an interface usable for people with varying tech literacy
- Doesn't offer financial assistance, sliding scale, or insurance coverage
Summary
- Clue demonstrates strong accuracy and clinical credibility with FDA clearance, peer-reviewed studies, and independent research—though it could better distinguish between its clinical and wellness features in product messaging.
- The app excels in inclusive design with diverse representation, LGBTQ+-inclusive language, multiple languages, and a free tier, but would benefit from improving accessibility standards like screen reader support and offering financial assistance options for underserved users.
- While Clue has robust GDPR protections and a strong privacy policy, it could strengthen user trust by clarifying its data-sharing practices with third parties and providing more granular controls over which vendors can access user information.
- The company is founded on genuine women's health expertise with active clinical advisors and public advocacy efforts, but should more clearly distinguish clinical features from wellness features to set appropriate user expectations.
Findings from our independent evaluation based on publicly available information and is intended to inform, not to recommend or discourage use of any product.
About This Product
- Clue is a science-based, data-driven menstrual and reproductive health app trusted by 10 million users globally. It serves as a period tracker, ovulation calculator, and comprehensive health resource with features for cycle tracking, fertility planning, pregnancy monitoring, and perimenopause management. The app is CE-marked as a Class 1 medical-grade device and developed in collaboration with leading health researchers at institutions such as Berkeley, MIT, and others.
Available In
- Global
About Biowink GmbH
- Founded in Berlin in 2012 by Ida Tin, who coined the term "femtech" and has spent 12 years as one of the category's most visible public advocates. The company is operated by BioWink GmbH and has raised approximately $64M, including a record-breaking equity crowdfunding round with 5,000+ investors, 85% of whom are women. Rhiannon White became CEO in late 2024.Clue has research partnerships with UC Berkeley, Oxford, MIT, and the Gates Foundation, and its dataset of 30B+ data points from 109 countries is among the largest menstrual health datasets.
Founders
Revenue Model
- Runs on a freemium subscription model.
- The free tier ("Clue Basic") covers core period tracking and cycle education; Clue Plus (~€1/month, one of the lowest premium price points in femtech) unlocks additional tracking modes, including Clue Birth Control, Clue Conceive, and expanded symptom analysis.
- Clue Plus has been FSA/HSA eligible in the US since January 2025.
- Payments are processed entirely through Apple App Store and Google Play, Clue never handles payment data directly.
- Secondary revenue comes from research partnerships with academic institutions and, more recently, healthcare and consumer health brand integrations, including partnerships with Oura, Headspace, Evaro (NHS-funded contraception), and Flex.
- These appear to be a growing revenue stream as Clue expands its ecosystem beyond the core app.
- Total funding is modest relative to peers at ~$64M, including a $9M round in 2023 and a Verdane investment announced in January 2026.
- Revenue figures are not publicly disclosed.
- Clue explicitly states that Clue Plus subscriptions support ongoing health research and help keep the free tier available, positioning the subscription as partially mission-driven rather than merely feature-gated.
- No advertising revenue, no data sales, no employer or insurance channel.
Links and documents reviewed during our SAFE evaluation of Clue.
Clinical Studies https://helloclue.com/articles/about-clue/scientific-research-at-clue Is Clue Conceive FDA cleared? https://support.helloclue.com/hc/en-us/articles/7955901467412-Is-Clue-Conceive-FDA-cleared Clue expands into digital contraception with FDA clearance https://www.mobihealthnews.com/news/clue-expands-digital-contraception-fda-clearance Clue Period Cycle Tracker Reviews (2026) https://justuseapp.com/en/app/657189652/clue-period-cycle-tracker/reviews How Clue's Evidence-Based Period Tracking Transforms Reproductive Health Awareness - Ourhealthstory.com https://ourhealthstory.com/slp-clue-period-tracking-app-features-20250126 Pricing Page https://helloclue.com/clue-plus Clue as of March 18 2026-Skynet-Technologies-Free-Accessibility-Checker-Report.pdf - Google Drive https://drive.google.com/file/d/1QIlrK81Frtt8X3cWidMc6aAplUlRpNhK/view?usp=drive_link Social Media https://www.tiktok.com/@clueapp About / Team Page https://helloclue.com/about-clue Blog / News https://helloclue.com/articles Website https://helloclue.com/ App Store https://apps.apple.com/us/app/clue-period-tracker-fertility/id657189652 Google Play https://play.google.com/store/apps/details?id=com.clue.android&hl=en FAQ / Help Center https://support.helloclue.com/hc/en-us Clue data to help close the diagnosis gap https://helloclue.com/articles/about-clue/clue-data-to-help-close-the-diagnosis-gap Clue Period & Cycle Tracker https://www.mozillafoundation.org/en/privacynotincluded/clue-period-cycle-tracker/ We asked five menstruation apps for our data and here is what we found... https://www.privacyinternational.org/long-read/4316/we-asked-five-menstruation-apps-our-data-and-here-what-we-found More than blood: app-tracking reveals variability in heavy menstrual bleeding construct https://link.springer.com/article/10.1186/s12905-023-02312-4 Clue Period Tracking App Review: Accurate Predictions and Privacy-First Design - Ourhealthstory.com https://ourhealthstory.com/slp-clue-period-tracking-app-review-20250108/ Clue Period Tracker App - Healtha.io https://healtha.io/apps/clue-period-tracker-and-calendar/ What are the Clue modes? https://support.helloclue.com/hc/en-us/articles/16701057975581-What-are-modes Privacy Policy https://helloclue.com/privacy Terms of Service https://helloclue.com/terms Why Clue's Data Privacy Pledge Sets It Apart in the Femtech Space https://appwhy.com/articles/why-clues-data-privacy-pledge-sets-it-apart-in-the-femtech-space Data and Period Tracking Apps: How we use data at Clue https://helloclue.com/articles/about-clue/the-journey-of-a-single-data-point Data Marketplace Selling Info About Who Uses Period Tracking Apps https://www.vice.com/en/article/data-marketplace-selling-clue-period-tracking-data/ Clue Period Tracker Review: The Truth About Its Accuracy and Annoying Ads https://www.smileblogs.com/article/2394Score History Coming Soon
Full score history tracking is on the way. You'll be able to see how a product's score has changed over time and why.